カテゴリー： 世界, 医療/バイオ, LP Information

世界のX線造影剤市場予測 2023年-2029年

【英語タイトル】Global Radiographic Contrast Agents Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC11021）・商品コード：LP23DC11021
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：93
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のX線造影剤市場」は、過去の販売実績から2022年の世界のX線造影剤の総販売量を検討し、2023年から2029年の予測されるX線造影剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のX線造影剤の市場規模を掲載し、XXX百万米ドル規模の世界のX線造影剤市場の詳細な分析を提供します。本インサイトレポートは、世界のX線造影剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のX線造影剤市場における各社の独自のポジションをより深く理解するために、X線造影剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のX線造影剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。X線造影剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。X線造影剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。X線造影剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

X線造影剤の世界主要メーカーとしては、Bracco、 GE Healthcare、 Bayer、 Guerbet Group、 Hengrui Medicine、 Lantheus、 YRPG、 BeiLu Pharmaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のX線造影剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではX線造影剤市場をセグメンテーションし、種類別 (レントゲン、CT)、用途別 (病院、クリニック)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：レントゲン、CT

・用途別区分：病院、クリニック

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のX線造影剤市場の10年間の市場状況・展望は？
・世界および地域別に見たX線造影剤市場成長の要因は何か？
・X線造影剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・X線造影剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：X線造影剤の年間販売量2018-2029、地域別現状・将来分析
・X線造影剤の種類別セグメント：レントゲン、CT
・X線造影剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・X線造影剤の用途別セグメント：病院、クリニック
・X線造影剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のX線造影剤市場
・企業別のグローバルX線造影剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別のX線造影剤の年間売上：2018-2023年の売上、市場シェア
・企業別のX線造影剤販売価格
・主要企業のX線造影剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

X線造影剤の地域別レビュー
・地域別のX線造影剤市場規模2018-2023：年間販売量、売上
・主要国別のX線造影剤市場規模2018-2023：年間販売量、売上
・南北アメリカのX線造影剤販売の成長
・アジア太平洋のX線造影剤販売の成長
・ヨーロッパのX線造影剤販売の成長
・中東・アフリカのX線造影剤販売の成長

南北アメリカ市場
・南北アメリカの国別のX線造影剤販売量、売上（2018-2023）
・南北アメリカのX線造影剤の種類別販売量
・南北アメリカのX線造影剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のX線造影剤販売量、売上（2018-2023）
・アジア太平洋のX線造影剤の種類別販売量
・アジア太平洋のX線造影剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のX線造影剤販売量、売上（2018-2023）
・ヨーロッパのX線造影剤の種類別販売量
・ヨーロッパのX線造影剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のX線造影剤販売量、売上（2018-2023）
・中東・アフリカのX線造影剤の種類別販売量
・中東・アフリカのX線造影剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・X線造影剤の製造コスト構造分析
・X線造影剤の製造プロセス分析
・X線造影剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・X線造影剤の主要なグローバル販売業者
・X線造影剤の主要なグローバル顧客

地域別のX線造影剤市場予測レビュー
・地域別のX線造影剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・X線造影剤の種類別市場規模予測
・X線造影剤の用途別市場規模予測

主要企業分析
Bracco、 GE Healthcare、 Bayer、 Guerbet Group、 Hengrui Medicine、 Lantheus、 YRPG、 BeiLu Pharma
・企業情報
・X線造影剤製品
・X線造影剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Radiographic Contrast Agents market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Radiographic Contrast Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Radiographic Contrast Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Radiographic Contrast Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Radiographic Contrast Agents players cover Bracco, GE Healthcare, Bayer, Guerbet Group, Hengrui Medicine, Lantheus, YRPG and BeiLu Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Radiographic Contrast Agents Industry Forecast” looks at past sales and reviews total world Radiographic Contrast Agents sales in 2022, providing a comprehensive analysis by region and market sector of projected Radiographic Contrast Agents sales for 2023 through 2029. With Radiographic Contrast Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiographic Contrast Agents industry.
This Insight Report provides a comprehensive analysis of the global Radiographic Contrast Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radiographic Contrast Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radiographic Contrast Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiographic Contrast Agents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiographic Contrast Agents.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiographic Contrast Agents market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
X-ray
CT
Segmentation by application
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Bracco
GE Healthcare
Bayer
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Radiographic Contrast Agents market?
What factors are driving Radiographic Contrast Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radiographic Contrast Agents market opportunities vary by end market size?
How does Radiographic Contrast Agents break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Radiographic Contrast Agents Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Radiographic Contrast Agents by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Radiographic Contrast Agents by Country/Region, 2018, 2022 & 2029
2.2 Radiographic Contrast Agents Segment by Type
2.2.1 X-ray
2.2.2 CT
2.3 Radiographic Contrast Agents Sales by Type
2.3.1 Global Radiographic Contrast Agents Sales Market Share by Type (2018-2023)
2.3.2 Global Radiographic Contrast Agents Revenue and Market Share by Type (2018-2023)
2.3.3 Global Radiographic Contrast Agents Sale Price by Type (2018-2023)
2.4 Radiographic Contrast Agents Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Radiographic Contrast Agents Sales by Application
2.5.1 Global Radiographic Contrast Agents Sale Market Share by Application (2018-2023)
2.5.2 Global Radiographic Contrast Agents Revenue and Market Share by Application (2018-2023)
2.5.3 Global Radiographic Contrast Agents Sale Price by Application (2018-2023)
3 Global Radiographic Contrast Agents by Company
3.1 Global Radiographic Contrast Agents Breakdown Data by Company
3.1.1 Global Radiographic Contrast Agents Annual Sales by Company (2018-2023)
3.1.2 Global Radiographic Contrast Agents Sales Market Share by Company (2018-2023)
3.2 Global Radiographic Contrast Agents Annual Revenue by Company (2018-2023)
3.2.1 Global Radiographic Contrast Agents Revenue by Company (2018-2023)
3.2.2 Global Radiographic Contrast Agents Revenue Market Share by Company (2018-2023)
3.3 Global Radiographic Contrast Agents Sale Price by Company
3.4 Key Manufacturers Radiographic Contrast Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radiographic Contrast Agents Product Location Distribution
3.4.2 Players Radiographic Contrast Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Radiographic Contrast Agents by Geographic Region
4.1 World Historic Radiographic Contrast Agents Market Size by Geographic Region (2018-2023)
4.1.1 Global Radiographic Contrast Agents Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Radiographic Contrast Agents Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Radiographic Contrast Agents Market Size by Country/Region (2018-2023)
4.2.1 Global Radiographic Contrast Agents Annual Sales by Country/Region (2018-2023)
4.2.2 Global Radiographic Contrast Agents Annual Revenue by Country/Region (2018-2023)
4.3 Americas Radiographic Contrast Agents Sales Growth
4.4 APAC Radiographic Contrast Agents Sales Growth
4.5 Europe Radiographic Contrast Agents Sales Growth
4.6 Middle East & Africa Radiographic Contrast Agents Sales Growth
5 Americas
5.1 Americas Radiographic Contrast Agents Sales by Country
5.1.1 Americas Radiographic Contrast Agents Sales by Country (2018-2023)
5.1.2 Americas Radiographic Contrast Agents Revenue by Country (2018-2023)
5.2 Americas Radiographic Contrast Agents Sales by Type
5.3 Americas Radiographic Contrast Agents Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiographic Contrast Agents Sales by Region
6.1.1 APAC Radiographic Contrast Agents Sales by Region (2018-2023)
6.1.2 APAC Radiographic Contrast Agents Revenue by Region (2018-2023)
6.2 APAC Radiographic Contrast Agents Sales by Type
6.3 APAC Radiographic Contrast Agents Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Radiographic Contrast Agents by Country
7.1.1 Europe Radiographic Contrast Agents Sales by Country (2018-2023)
7.1.2 Europe Radiographic Contrast Agents Revenue by Country (2018-2023)
7.2 Europe Radiographic Contrast Agents Sales by Type
7.3 Europe Radiographic Contrast Agents Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Radiographic Contrast Agents by Country
8.1.1 Middle East & Africa Radiographic Contrast Agents Sales by Country (2018-2023)
8.1.2 Middle East & Africa Radiographic Contrast Agents Revenue by Country (2018-2023)
8.2 Middle East & Africa Radiographic Contrast Agents Sales by Type
8.3 Middle East & Africa Radiographic Contrast Agents Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radiographic Contrast Agents
10.3 Manufacturing Process Analysis of Radiographic Contrast Agents
10.4 Industry Chain Structure of Radiographic Contrast Agents
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radiographic Contrast Agents Distributors
11.3 Radiographic Contrast Agents Customer
12 World Forecast Review for Radiographic Contrast Agents by Geographic Region
12.1 Global Radiographic Contrast Agents Market Size Forecast by Region
12.1.1 Global Radiographic Contrast Agents Forecast by Region (2024-2029)
12.1.2 Global Radiographic Contrast Agents Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Radiographic Contrast Agents Forecast by Type
12.7 Global Radiographic Contrast Agents Forecast by Application
13 Key Players Analysis
13.1 Bracco
13.1.1 Bracco Company Information
13.1.2 Bracco Radiographic Contrast Agents Product Portfolios and Specifications
13.1.3 Bracco Radiographic Contrast Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bracco Main Business Overview
13.1.5 Bracco Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare Radiographic Contrast Agents Product Portfolios and Specifications
13.2.3 GE Healthcare Radiographic Contrast Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Radiographic Contrast Agents Product Portfolios and Specifications
13.3.3 Bayer Radiographic Contrast Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Guerbet Group
13.4.1 Guerbet Group Company Information
13.4.2 Guerbet Group Radiographic Contrast Agents Product Portfolios and Specifications
13.4.3 Guerbet Group Radiographic Contrast Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Guerbet Group Main Business Overview
13.4.5 Guerbet Group Latest Developments
13.5 Hengrui Medicine
13.5.1 Hengrui Medicine Company Information
13.5.2 Hengrui Medicine Radiographic Contrast Agents Product Portfolios and Specifications
13.5.3 Hengrui Medicine Radiographic Contrast Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hengrui Medicine Main Business Overview
13.5.5 Hengrui Medicine Latest Developments
13.6 Lantheus
13.6.1 Lantheus Company Information
13.6.2 Lantheus Radiographic Contrast Agents Product Portfolios and Specifications
13.6.3 Lantheus Radiographic Contrast Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Lantheus Main Business Overview
13.6.5 Lantheus Latest Developments
13.7 YRPG
13.7.1 YRPG Company Information
13.7.2 YRPG Radiographic Contrast Agents Product Portfolios and Specifications
13.7.3 YRPG Radiographic Contrast Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 YRPG Main Business Overview
13.7.5 YRPG Latest Developments
13.8 BeiLu Pharma
13.8.1 BeiLu Pharma Company Information
13.8.2 BeiLu Pharma Radiographic Contrast Agents Product Portfolios and Specifications
13.8.3 BeiLu Pharma Radiographic Contrast Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 BeiLu Pharma Main Business Overview
13.8.5 BeiLu Pharma Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Radiographic Contrast Agents Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Radiographic Contrast Agents Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of X-ray
Table 4. Major Players of CT
Table 5. Global Radiographic Contrast Agents Sales by Type (2018-2023) & (K Units)
Table 6. Global Radiographic Contrast Agents Sales Market Share by Type (2018-2023)
Table 7. Global Radiographic Contrast Agents Revenue by Type (2018-2023) & ($ million)
Table 8. Global Radiographic Contrast Agents Revenue Market Share by Type (2018-2023)
Table 9. Global Radiographic Contrast Agents Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Radiographic Contrast Agents Sales by Application (2018-2023) & (K Units)
Table 11. Global Radiographic Contrast Agents Sales Market Share by Application (2018-2023)
Table 12. Global Radiographic Contrast Agents Revenue by Application (2018-2023)
Table 13. Global Radiographic Contrast Agents Revenue Market Share by Application (2018-2023)
Table 14. Global Radiographic Contrast Agents Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Radiographic Contrast Agents Sales by Company (2018-2023) & (K Units)
Table 16. Global Radiographic Contrast Agents Sales Market Share by Company (2018-2023)
Table 17. Global Radiographic Contrast Agents Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Radiographic Contrast Agents Revenue Market Share by Company (2018-2023)
Table 19. Global Radiographic Contrast Agents Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Radiographic Contrast Agents Producing Area Distribution and Sales Area
Table 21. Players Radiographic Contrast Agents Products Offered
Table 22. Radiographic Contrast Agents Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Radiographic Contrast Agents Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Radiographic Contrast Agents Sales Market Share Geographic Region (2018-2023)
Table 27. Global Radiographic Contrast Agents Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Radiographic Contrast Agents Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Radiographic Contrast Agents Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Radiographic Contrast Agents Sales Market Share by Country/Region (2018-2023)
Table 31. Global Radiographic Contrast Agents Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Radiographic Contrast Agents Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Radiographic Contrast Agents Sales by Country (2018-2023) & (K Units)
Table 34. Americas Radiographic Contrast Agents Sales Market Share by Country (2018-2023)
Table 35. Americas Radiographic Contrast Agents Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Radiographic Contrast Agents Revenue Market Share by Country (2018-2023)
Table 37. Americas Radiographic Contrast Agents Sales by Type (2018-2023) & (K Units)
Table 38. Americas Radiographic Contrast Agents Sales by Application (2018-2023) & (K Units)
Table 39. APAC Radiographic Contrast Agents Sales by Region (2018-2023) & (K Units)
Table 40. APAC Radiographic Contrast Agents Sales Market Share by Region (2018-2023)
Table 41. APAC Radiographic Contrast Agents Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Radiographic Contrast Agents Revenue Market Share by Region (2018-2023)
Table 43. APAC Radiographic Contrast Agents Sales by Type (2018-2023) & (K Units)
Table 44. APAC Radiographic Contrast Agents Sales by Application (2018-2023) & (K Units)
Table 45. Europe Radiographic Contrast Agents Sales by Country (2018-2023) & (K Units)
Table 46. Europe Radiographic Contrast Agents Sales Market Share by Country (2018-2023)
Table 47. Europe Radiographic Contrast Agents Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Radiographic Contrast Agents Revenue Market Share by Country (2018-2023)
Table 49. Europe Radiographic Contrast Agents Sales by Type (2018-2023) & (K Units)
Table 50. Europe Radiographic Contrast Agents Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Radiographic Contrast Agents Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Radiographic Contrast Agents Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Radiographic Contrast Agents Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Radiographic Contrast Agents Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Radiographic Contrast Agents Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Radiographic Contrast Agents Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Radiographic Contrast Agents
Table 58. Key Market Challenges & Risks of Radiographic Contrast Agents
Table 59. Key Industry Trends of Radiographic Contrast Agents
Table 60. Radiographic Contrast Agents Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Radiographic Contrast Agents Distributors List
Table 63. Radiographic Contrast Agents Customer List
Table 64. Global Radiographic Contrast Agents Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Radiographic Contrast Agents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Radiographic Contrast Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Radiographic Contrast Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Radiographic Contrast Agents Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Radiographic Contrast Agents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Radiographic Contrast Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Radiographic Contrast Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Radiographic Contrast Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Radiographic Contrast Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Radiographic Contrast Agents Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Radiographic Contrast Agents Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Radiographic Contrast Agents Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Radiographic Contrast Agents Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Bracco Basic Information, Radiographic Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 79. Bracco Radiographic Contrast Agents Product Portfolios and Specifications
Table 80. Bracco Radiographic Contrast Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Bracco Main Business
Table 82. Bracco Latest Developments
Table 83. GE Healthcare Basic Information, Radiographic Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 84. GE Healthcare Radiographic Contrast Agents Product Portfolios and Specifications
Table 85. GE Healthcare Radiographic Contrast Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. GE Healthcare Main Business
Table 87. GE Healthcare Latest Developments
Table 88. Bayer Basic Information, Radiographic Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 89. Bayer Radiographic Contrast Agents Product Portfolios and Specifications
Table 90. Bayer Radiographic Contrast Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Bayer Main Business
Table 92. Bayer Latest Developments
Table 93. Guerbet Group Basic Information, Radiographic Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 94. Guerbet Group Radiographic Contrast Agents Product Portfolios and Specifications
Table 95. Guerbet Group Radiographic Contrast Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Guerbet Group Main Business
Table 97. Guerbet Group Latest Developments
Table 98. Hengrui Medicine Basic Information, Radiographic Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 99. Hengrui Medicine Radiographic Contrast Agents Product Portfolios and Specifications
Table 100. Hengrui Medicine Radiographic Contrast Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Hengrui Medicine Main Business
Table 102. Hengrui Medicine Latest Developments
Table 103. Lantheus Basic Information, Radiographic Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 104. Lantheus Radiographic Contrast Agents Product Portfolios and Specifications
Table 105. Lantheus Radiographic Contrast Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Lantheus Main Business
Table 107. Lantheus Latest Developments
Table 108. YRPG Basic Information, Radiographic Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 109. YRPG Radiographic Contrast Agents Product Portfolios and Specifications
Table 110. YRPG Radiographic Contrast Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. YRPG Main Business
Table 112. YRPG Latest Developments
Table 113. BeiLu Pharma Basic Information, Radiographic Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 114. BeiLu Pharma Radiographic Contrast Agents Product Portfolios and Specifications
Table 115. BeiLu Pharma Radiographic Contrast Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. BeiLu Pharma Main Business
Table 117. BeiLu Pharma Latest Developments
List of Figures
Figure 1. Picture of Radiographic Contrast Agents
Figure 2. Radiographic Contrast Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiographic Contrast Agents Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Radiographic Contrast Agents Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Radiographic Contrast Agents Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of X-ray
Figure 10. Product Picture of CT
Figure 11. Global Radiographic Contrast Agents Sales Market Share by Type in 2022
Figure 12. Global Radiographic Contrast Agents Revenue Market Share by Type (2018-2023)
Figure 13. Radiographic Contrast Agents Consumed in Hospitals
Figure 14. Global Radiographic Contrast Agents Market: Hospitals (2018-2023) & (K Units)
Figure 15. Radiographic Contrast Agents Consumed in Clinics
Figure 16. Global Radiographic Contrast Agents Market: Clinics (2018-2023) & (K Units)
Figure 17. Global Radiographic Contrast Agents Sales Market Share by Application (2022)
Figure 18. Global Radiographic Contrast Agents Revenue Market Share by Application in 2022
Figure 19. Radiographic Contrast Agents Sales Market by Company in 2022 (K Units)
Figure 20. Global Radiographic Contrast Agents Sales Market Share by Company in 2022
Figure 21. Radiographic Contrast Agents Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Radiographic Contrast Agents Revenue Market Share by Company in 2022
Figure 23. Global Radiographic Contrast Agents Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Radiographic Contrast Agents Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Radiographic Contrast Agents Sales 2018-2023 (K Units)
Figure 26. Americas Radiographic Contrast Agents Revenue 2018-2023 ($ Millions)
Figure 27. APAC Radiographic Contrast Agents Sales 2018-2023 (K Units)
Figure 28. APAC Radiographic Contrast Agents Revenue 2018-2023 ($ Millions)
Figure 29. Europe Radiographic Contrast Agents Sales 2018-2023 (K Units)
Figure 30. Europe Radiographic Contrast Agents Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Radiographic Contrast Agents Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Radiographic Contrast Agents Revenue 2018-2023 ($ Millions)
Figure 33. Americas Radiographic Contrast Agents Sales Market Share by Country in 2022
Figure 34. Americas Radiographic Contrast Agents Revenue Market Share by Country in 2022
Figure 35. Americas Radiographic Contrast Agents Sales Market Share by Type (2018-2023)
Figure 36. Americas Radiographic Contrast Agents Sales Market Share by Application (2018-2023)
Figure 37. United States Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Radiographic Contrast Agents Sales Market Share by Region in 2022
Figure 42. APAC Radiographic Contrast Agents Revenue Market Share by Regions in 2022
Figure 43. APAC Radiographic Contrast Agents Sales Market Share by Type (2018-2023)
Figure 44. APAC Radiographic Contrast Agents Sales Market Share by Application (2018-2023)
Figure 45. China Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Radiographic Contrast Agents Sales Market Share by Country in 2022
Figure 53. Europe Radiographic Contrast Agents Revenue Market Share by Country in 2022
Figure 54. Europe Radiographic Contrast Agents Sales Market Share by Type (2018-2023)
Figure 55. Europe Radiographic Contrast Agents Sales Market Share by Application (2018-2023)
Figure 56. Germany Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Radiographic Contrast Agents Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Radiographic Contrast Agents Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Radiographic Contrast Agents Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Radiographic Contrast Agents Sales Market Share by Application (2018-2023)
Figure 65. Egypt Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Radiographic Contrast Agents Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Radiographic Contrast Agents in 2022
Figure 71. Manufacturing Process Analysis of Radiographic Contrast Agents
Figure 72. Industry Chain Structure of Radiographic Contrast Agents
Figure 73. Channels of Distribution
Figure 74. Global Radiographic Contrast Agents Sales Market Forecast by Region (2024-2029)
Figure 75. Global Radiographic Contrast Agents Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Radiographic Contrast Agents Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Radiographic Contrast Agents Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Radiographic Contrast Agents Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Radiographic Contrast Agents Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のX線造影剤市場予測 2023年-2029年] (コード：LP23DC11021)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のX線造影剤市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のRAS作用剤市場予測 2023年-2029年
  • 世界のRAS作用剤市場予測 2023年-2029年
  • 世界のアルカリ化剤市場予測 2023年-2029年
  • 世界の蚊よけ用仕上げ剤市場予測 2023年-2029年
  • 世界の航空宇宙用離型剤市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆